27 October 2020 : Review article
Prognosis and Treatment of Liver Transplant Recipients in the COVID-19 Era: A Literature Review
Ashraf Imam1ADEFG, Sadi A. Abukhalaf1ABCDEF, Hadar Merhav1CDFG, Samir Abu-Gazala1ABDG, Oded Cohen-Arazi1BCEG, Alon Josef Pikarsky1DEFG, Rifaat Safadi2EFG, Abed Khalaileh1AEFG*DOI: 10.12659/AOT.926196
Ann Transplant 2020; 25:e926196
Table 3 Characteristics of all available reported liver transplant recipients infected with COVID-19.
| Study; Country | Age | Sex | Time from transplant (years) | Comorbidities | Clinical presentation | Highest temp (°C) | Baseline ISM |
|---|---|---|---|---|---|---|---|
| Zhong; China []30 | 37 | M | 9 days | Fever 38.6°C, Weakness, Abdominal discomfort, sleep disorders | 38.6 | Tac, IVMP | |
| Liu; China []31 | 50 | M | 2.5 | Fever 37.7°C, SOB, | 39.6 | Tac, | |
| Huang; China []32 | 59 | M | 2.7 | Fever 40, Cough, Chills, Fatigue, Diarrhea, Jaundice, Splenomegaly, Ascites, | 40 | Tac, MMF | |
| Qin; China []33 | 37 | M | 12 days | Fever 39, | 39 | Tac, Pred | |
| Morand; France []34 | 4.6 | F | 5 months | Fever, Cough, SOB, Rhinitis, | Tac | ||
| Lagana; USA []35 | 6 months | F | 2 days | Fever, SOB, Diarrhea | MMF | ||
| Kates; USA []36 | 67 | M | 19 | Fever, Cough, Fatigue, confusion, Diarrhea, Wheezing | cyclosporine | ||
| Hammami; USA []37 | 63 | M | 9.5 | HTN, DM, ESRD, PVD, CHF, | Fever 38.3, Cough, Headache, Fatigue, Myalgia, Chest pain, Chills, Abdominal pain, | 39.1 | Tac, |
| Fernández-Ruiz; Spain []38 | 63 | M | 7.9 | HTN, DM | Fever, SOB, Cough, Myalgia, Fatigue, Diarrhea | everolimus | |
| 72 | M | 5.5 | HTN, DM, Obesity, | Fever, SOB, Cough, | MMF, everolimus | ||
| 79 | F | 15.3 | DM, ESRD, | SOB, Cough, Fatigue, Diarrhea | Everolimus, Pred, azathioprine | ||
| 73 | M | 16.4 | DM, Asthma, bronchiectasis | Fever, SOB, Cough, Fatigue, | MMF | ||
| 76 | F | 26.5 | HTN | Fever, Chest pain | Tac | ||
| 46 | F | 6.4 | Diarrhea | Tac | |||
| Donato; Italy []39 | 60 | M | 3 | Fever, Respiratory symptoms | Tac, MMF | ||
| 78 | M | 19.1 | Heart Disease | Fever, Respiratory symptoms | Tac, MMF | ||
| 65 | M | 5.4 | Lung disease | Fever, Respiratory symptoms | Pred | ||
| 57 | M | 15.6 | Heart and lung diseases | Fever, Respiratory symptoms | Tac, MMF | ||
| 57 | M | 8 | Fever, Respiratory symptoms | Tac, MMF | |||
| 62 | F | 11.4 | Lung disease | Fever, Respiratory symptoms | Tac, MMF | ||
| 75 | M | 17.6 | Heart disease | Fever, Diarrhea | Tac, MMF | ||
| 50 | F | 3 months | Heart and lung diseases | Fever, Respiratory symptoms | Tac, Pred |